Pharmaceutical

New treatment for pelvic organ prolapse less risky than transvaginal mesh

vaginal mesh sling New treatment for pelvic organ prolapse less risky than transvaginal meshWomen who suffer from common pelvic floor disorders such as pelvic organ prolapse (POP) or stress urinary incontinence (SUI) can experience uncomfortable or embarrassing symptoms including pain and incontinence. Unfortunately, in 2011, the Food and Drug Administration (FDA) warned that the most popular surgical procedure used to treat the condition – a process in which surgical mesh is inserted through the vagina to hold up prolapsed organs – was associated with a large number of complications. Problems involved the mesh eroding in tissue causing infections, pain, disability, and hemorrhaging. Some women had to undergo repeated surgeries to remove the mesh, and some deaths were even reported.

Since the FDA issued the warning about transvaginal mesh surgery, robotic sacrocolpopexy has become the most popular procedure for pelvic organ prolapse and stress urinary incontinence repair. This minimally invasive surgery involves making small incisions into the lower abdomen and using a small piece of mesh to secure the cervix, vagina and bladder to the sacral bone. The procedure carries a much smaller risk than mesh inserted vaginally.

Patients who are considering treatment for pelvic floor disorders should discuss options with their doctors. Women who have had surgery to implant surgical mesh transvaginally and experienced problems even months or years after having it implanted may be entitled to compensation for their pain and suffering.

However, time is running out. In many states, the two-year statute of limitations is approaching for women to file lawsuits against the manufacturers of transvaginal mesh.

Attorneys at Beasley Allen Law Firm are currently investigating cases of injury associated with transvaginal mesh.

Source: Miami Herald